Institution
Transgene SA
Company•Illkirch-Graffenstaden, France•
About: Transgene SA is a company organization based out in Illkirch-Graffenstaden, France. It is known for research contribution in the topics: Antigen & Genetic enhancement. The organization has 377 authors who have published 296 publications receiving 12537 citations.
Topics: Antigen, Genetic enhancement, Immune system, Gene, Cytotoxic T cell
Papers published on a yearly basis
Papers
More filters
Patent•
23 Mar 2010TL;DR: In this article, a method for determining the efficacy of certain immunotherapy treatments is presented, which includes measuring a biomarker at some time following the initiation of immunotherapy treatment to evaluate the clinical outcome of the said treatment.
Abstract: The present invention is in the field of immunotherapy and relates to methods for determining the efficacy of certain immunotherapy treatments. The methods of the invention include measuring special biomarker at some time following the initiation of immunotherapy treatment to evaluate the clinical outcome of the said treatment. The invention thus has applications to the field of medicine.
5 citations
Patent•
10 Sep 1997TL;DR: In this article, a method for preparing a plasmid DNA using a wet cell biomass comprising after resuspension of said biomass the following steps:, alkaline lysis, high ionic strength acidification, elimination of solubles, endotoxin and contaminating RNA reduction, filtering gel chromatography and conditioning.
Abstract: The invention concerns a method for preparing a plasmid DNA using a wet cell biomass comprising after resuspension of said biomass the following steps:, alkaline lysis, high ionic strength acidification, elimination of solubles, endotoxin and contaminating RNA reduction, filtering gel chromatography and conditioning. The invention also concerns a pharmaceutical composition containing a plasmid DNA and its use for gene therapy.
5 citations
TL;DR: This MAb panel is useful for probing the recombinant C-terminal integrity of hirudin, for sensitive free hirUDin quantitations, and the combined use of two MAbs has potential applications as an antidote for hir Hudin in vivo.
5 citations
TL;DR: Bacillus sphaericus was treated with N-acetylmuramidase and transformed with different bioB expression vectors by protoplast transformation, of which only three could be introduced into B. sphasericus, and a vector containing bioB under the control of the "HpaII promoter" on pUB110 accumulated 20 μg of biotin/ml in the medium.
5 citations
Patent•
01 Dec 1987TL;DR: A vector is a part of the genome of a vector virus, including the complete gag gene or one of its subfragments as mentioned in this paper, and the elements ensuring the expression of this protein in eukaryote cells.
Abstract: Viral vector comprising at least: - a part of the genome of a vector virus, - the complete gag gene or one of its subfragments, especially a gene coding for the p25 protein or a gene coding for the p18 protein of the HIV virus responsible for AIDS, - and the elements ensuring the expression of this protein in eukaryote cells in a culture.
5 citations
Authors
Showing all 378 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Xuetao Cao | 95 | 509 | 35318 |
| Luc Montagnier | 76 | 410 | 30740 |
| Simon Wain-Hobson | 62 | 235 | 16013 |
| Catherine Tomasetto | 57 | 139 | 10479 |
| Rainer Bischoff | 54 | 327 | 10146 |
| Richard Lathe | 52 | 172 | 19962 |
| Margaret A. Liu | 47 | 97 | 10503 |
| Georges Lacaud | 45 | 102 | 5905 |
| Jean-Yves Bonnefoy | 44 | 93 | 6368 |
| Klaus Schughart | 40 | 157 | 6438 |
| Michael Antoniou | 40 | 129 | 5158 |
| Andrea Pavirani | 39 | 104 | 8283 |
| A Capron | 39 | 129 | 4826 |
| Jean-Pierre Lecocq | 37 | 125 | 7122 |
| Stéphane Paul | 36 | 199 | 4592 |